The world’s largest childhood myopia education resource developed by Australian optometry couple Dr Kate and Dr Paul Gifford has formed a new alliance with the renowned Centre for Ocular Research & Education (CORE). Read more

The world’s largest childhood myopia education resource developed by Australian optometry couple Dr Kate and Dr Paul Gifford has formed a new alliance with the renowned Centre for Ocular Research & Education (CORE). Read more
A Melbourne professor has helped lead new research using a gene therapy to regenerate damaged optic nerve fibres, in a discovery that could determine future glaucoma treatments. Read more
A concentration of 0.05% atropine slowed the rate of myopia progression in pre-teen children compared with two other concentrations of the drug, according to findings published in Ophthalmology. Read more
A new study has suggested the cornea can resist infection from the novel coronavirus, in findings that bode well for corneal transplants and similar procedures. Read more
Half of the Australian population is experiencing negative impacts to their eyesight due to rapidly changing lifestyles in 2020, according to new research from Zeiss. Read more
A Victorian biopharmaceutical company has reported positive results from a Phase 1 study examining the safety of its biodegradable implant for glaucoma. Read more
The Centre for Eye Research Australia (CERA) has established a new research unit to improve current eyecare models and tackle the backlog of undiagnosed and untreated conditions brought on by the COVID-19 pandemic. Read more
New research commissioned by a major optometry provider has found 60% of Australians aren’t aware the sun can cause permanent eye damage through conditions such as cataracts, cancer or macular degeneration. Read more
Specsavers has launched its new HealthHub website to share updates on detection, referral and treatment progress for key eye conditions, as well as the use of optometry services in New Zealand and Australia. Read more
An optometrist-turned-research fellow leading a world-first clinical trial investigating whether daily doses of vitamin B3 could prevent glaucoma blindness has been awarded Glaucoma Australia (GA)’s 2020 Quinlivan Research Grant. Read more